Discover 1,024 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,024
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
for
Multiple Myeloma
Location: Minneapolis MN
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT03127761
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis
for
Myelofibrosis
Location: Minneapolis MN
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 55+
Code: NCT02934477
Recruiting
CIBMTR Research Database
for
Autologous Stem Cell Transplantation,
Location: Minneapolis MN, Milwaukee WI
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01166009
Recruiting
University of Minnesota Transplant Registry
for
Transplant Recipient, Transplant Donation
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 0+
Code: NCT01062581
Recruiting
Exploration of the Utility of Dental-dedicated MRI for Dentistry
for
Dental Crowding, Dental Occlusion, Traumatic,
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 18+
Code: NCT06948162
Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
for
Hormone Receptor Positive HER-2 Negative Breast Cancer,
Location: Minneapolis MN, Rochester MN, Chicago IL,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06369285
Phase 2, Recruiting
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Minneapolis MN, Chicago IL, St Louis MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 18
Code: NCT06247787
Phase 1, Recruiting
A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
for
Solid Tumors
Location: Minneapolis MN, Grand Rapids MI, Fairfax VA,
Sponsor: Adcentrx Therapeutics
Sex: All
Age: 18+
Code: NCT06710379
Phase 1, Recruiting
Adrenoleukodystrophy National Registry Study
for
ALD (Adrenoleukodystrophy), Adrenoleukodystrophy,
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota
Sex: All
Age: 0+
Code: NCT03789721
Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
for
Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)
Location: Minneapolis MN, Zion IL, Detroit MI, Louisville KY,
Sponsor: J-Pharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT07265674
Phase 3, Recruiting
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
for
Neuroblastoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota
Sex: All
Age: 0 - 30
Code: NCT02605421
Phase 2, Recruiting
Auto Stem Cell Transplant for Lymphoma Patients
for
Non-Hodgkin Lymphoma, Hodgkin Lymphoma
Location: Minneapolis MN
Sponsor: Masonic Cancer Center, University of Minnesota
Sex: All
Age: 0 - 70+
Code: NCT03125642
Phase 2, Recruiting
Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Minneapolis MN, Columbus OH, Richmond VA
Sponsor: Yazeed Sawalha
Sex: All
Age: 18+
Code: NCT06536049
Phase 1, Phase 2, Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Location: Minneapolis MN, Chicago IL, St Louis MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT04851119
Phase 1, Phase 2, Recruiting
Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
Ovarian Cancer, Fallopian Tube, Primary Peritoneal Cancer